Wuhan Easy Diagnosis Biomedicine Co.,Ltd.’s Net Profit Rose 187.1% in First Three Quarters of 2021

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (武汉明德生物科技股份有限公司) (002932.SZ) reported a net profit of 1 billion yuan in the first three quarters of 2021, up 187.1% year-on-year.

Meanwhile, the company posted 1.9 billion yuan in revenue, up 202.8% year-on-year.

At the end of the reporting period, it had 2.3 billion yuan in total assets and 369.8 million yuan in total liabilities, with a liability-to-asset ratio of 16.1%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.